Jeff Garro
Stock Analyst at Stephens & Co.
(0.94)
# 3,965
Out of 5,113 analysts
57
Total ratings
35.9%
Success rate
-10.39%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Maintains: Overweight | $15 → $12 | $10.00 | +20.00% | 6 | Dec 12, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $23.94 | +33.67% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $11.92 | +42.62% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $3.94 | +128.43% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $15.84 | +102.02% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $20.84 | -4.03% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.62 | +35.79% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $222.00 | +26.13% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.25 | +122.22% | 4 | Mar 6, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.43 | +105.76% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $40.63 | +35.37% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $235.31 | +6.24% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $20.00 | -15.00% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $6.33 | +342.34% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $23.81 | -16.00% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.81 | -32.87% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.64 | +82.93% | 3 | May 6, 2022 |
Certara
Dec 12, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $10.00
Upside: +20.00%
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.94
Upside: +33.67%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $11.92
Upside: +42.62%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $3.94
Upside: +128.43%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $15.84
Upside: +102.02%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $20.84
Upside: -4.03%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.62
Upside: +35.79%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $222.00
Upside: +26.13%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.25
Upside: +122.22%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.43
Upside: +105.76%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $40.63
Upside: +35.37%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $235.31
Upside: +6.24%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $20.00
Upside: -15.00%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $6.33
Upside: +342.34%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $23.81
Upside: -16.00%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.81
Upside: -32.87%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.64
Upside: +82.93%